BRPI0510136A - prodrogas esteróides com efeito androgênico - Google Patents

prodrogas esteróides com efeito androgênico

Info

Publication number
BRPI0510136A
BRPI0510136A BRPI0510136-0A BRPI0510136A BRPI0510136A BR PI0510136 A BRPI0510136 A BR PI0510136A BR PI0510136 A BRPI0510136 A BR PI0510136A BR PI0510136 A BRPI0510136 A BR PI0510136A
Authority
BR
Brazil
Prior art keywords
androgenic
steroids
effect
androgenic effect
steroidal
Prior art date
Application number
BRPI0510136-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ralf Wyrwa
Peter Droescher
Sven Ring
Walter Elger
Birgitt Schneider
Alexander Hillisch
Gudrun Reddersen
Original Assignee
Schering Aktiengellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengellschaft filed Critical Schering Aktiengellschaft
Publication of BRPI0510136A publication Critical patent/BRPI0510136A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BRPI0510136-0A 2004-05-21 2005-05-10 prodrogas esteróides com efeito androgênico BRPI0510136A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung
PCT/EP2005/005256 WO2005113575A1 (de) 2004-05-21 2005-05-10 Steroid-prodrugs mit androgener wirkung

Publications (1)

Publication Number Publication Date
BRPI0510136A true BRPI0510136A (pt) 2007-10-02

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510136-0A BRPI0510136A (pt) 2004-05-21 2005-05-10 prodrogas esteróides com efeito androgênico

Country Status (22)

Country Link
EP (1) EP1747229A1 (zh)
JP (1) JP2007538026A (zh)
CN (1) CN1993375A (zh)
AR (1) AR049547A1 (zh)
AU (1) AU2005245568A1 (zh)
BR (1) BRPI0510136A (zh)
CA (1) CA2564963A1 (zh)
CR (1) CR8785A (zh)
DE (1) DE102004025986A1 (zh)
EA (1) EA200602049A1 (zh)
EC (1) ECSP067028A (zh)
GT (1) GT200500122A (zh)
IL (1) IL179293A0 (zh)
MX (1) MXPA06013469A (zh)
NO (1) NO20065885L (zh)
PA (1) PA8633601A1 (zh)
PE (1) PE20060271A1 (zh)
SV (1) SV2006002123A (zh)
TW (1) TW200613317A (zh)
UY (1) UY28911A1 (zh)
WO (1) WO2005113575A1 (zh)
ZA (1) ZA200610769B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) * 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
WO2005113575A1 (de) 2005-12-01
GT200500122A (es) 2006-01-24
CA2564963A1 (en) 2005-12-01
IL179293A0 (en) 2007-03-08
SV2006002123A (es) 2006-02-15
JP2007538026A (ja) 2007-12-27
CN1993375A (zh) 2007-07-04
AU2005245568A1 (en) 2005-12-01
PE20060271A1 (es) 2006-05-25
UY28911A1 (es) 2005-12-30
EA200602049A1 (ru) 2007-06-29
DE102004025986A1 (de) 2005-12-15
NO20065885L (no) 2006-12-19
CR8785A (es) 2007-02-05
EP1747229A1 (de) 2007-01-31
ECSP067028A (es) 2006-12-29
PA8633601A1 (es) 2006-07-03
AR049547A1 (es) 2006-08-16
TW200613317A (en) 2006-05-01
ZA200610769B (en) 2008-08-27
MXPA06013469A (es) 2007-01-23

Similar Documents

Publication Publication Date Title
BRPI0510136A (pt) prodrogas esteróides com efeito androgênico
ECSP099452A (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
BR112015019590A2 (pt) derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv
ECSP088975A (es) Nuevos análagos de piridina
CO6351783A2 (es) Derivados de indazoles sustituidos con fenilo o piridinilo
BR112015005168A2 (pt) Derivados de c17-alcanodiila e alquenodiila de ácido oleanólico e métodos de uso dos mesmos
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
BR112012007085B8 (pt) processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
BR112012030810A2 (pt) "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv"
CR10192A (es) Compuestos de amido y su uso como productos farmaceuticos
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
BRPI0907789A2 (pt) derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos
CR20150007A (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos
BRPI0714553B8 (pt) derivados de camptotecina, processo para preparação dos mesmos, composição farmacêutica e seu uso
HN2011002578A (es) Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide.
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
UY28909A1 (es) Prodrogas de estradiol
ECSP088472A (es) Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento
UY32081A (es) Nuevas heteroarilcarboxamidas, su preparación y su uso como medicamentos
ECSP099040A (es) Nuevos análogos de piridina
BRPI0911622B8 (pt) derivados de benzoxepina e benzociclo-heptano, seu processo de preparação, seu uso e composição farmacêutica que os compreende
BR112014005034A2 (pt) compostos e composições de fragrância
CR9981A (es) Prodrogas de sustancias erb-selectivas, procesos para su preparacion y composiciones farmaceuticas que comprenden estos productos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]